These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 4566777)

  • 1. The use of urokinase, pyridinolcarbamate, and dypiridamole in rat heart allografts.
    Ono K; Hattori T; Inokuchi K
    Surgery; 1973 Jan; 73(1):128-32. PubMed ID: 4566777
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of treatment on the arterial lesions of rat and rabbit cardiac allografts.
    Laden AM
    Transplantation; 1972 Mar; 13(3):281-90. PubMed ID: 4553731
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on FK506 in experimental organ transplantation.
    Ochiai T; Sakamoto K; Nagata M; Nakajima K; Goto T; Hori S; Kenmochi T; Nakagori T; Asano T; Isono K
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):209-14. PubMed ID: 2450414
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of the efficacy of immunosuppressive regimens on orthotopic heart allografts.
    Kondo Y; Grogan JB; Cockrell JV; Kuramochi T; Smith GV; Hardy JD
    J Thorac Cardiovasc Surg; 1974 Apr; 67(4):612-20. PubMed ID: 4594431
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of pyridinolcarbamate on blood coagulation and thrombolysis in patients with arteriosclerosis obliterans].
    Hess H; Goossens N; Keil-Kuri E; Zollner R; Meyer A
    Vasa; 1972; 1(3):206-11. PubMed ID: 5076123
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiac allograft pathology in Rhesus monkeys.
    Hollander CF
    Am J Phys Anthropol; 1973 Mar; 38(2):431-3. PubMed ID: 4632089
    [No Abstract]   [Full Text] [Related]  

  • 7. Passenger cells in rat heart allografts. No effect of removal.
    Nielsen HE; Heron I; Koch C
    Transplantation; 1975 Apr; 19(4):360-3. PubMed ID: 1098240
    [No Abstract]   [Full Text] [Related]  

  • 8. [Development of new immunosuppressant and experimental cardiac transplantation].
    Ochiai T
    Tanpakushitsu Kakusan Koso; 1990 Jul; 35(10):1961-8. PubMed ID: 2236608
    [No Abstract]   [Full Text] [Related]  

  • 9. Reversal of ongoing rejection of allografts by rapamycin.
    Chen HF; Wu JP; Luo HY; Daloze PM
    Transplant Proc; 1991 Aug; 23(4):2241-2. PubMed ID: 1871859
    [No Abstract]   [Full Text] [Related]  

  • 10. Pathogenesis and prevention of graft arteriosclerosis in an experimental heart transplant model.
    Lurie KG; Billingham ME; Jamieson SW; Harrison DC; Reitz BA
    Transplantation; 1981 Jan; 31(1):41-7. PubMed ID: 7015599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of low molecular weight heparin on suppression of chronic graft vascular disease in a rat cardiac allograft model.
    Teranishi K; Poston RS; Reitz BA; Robbins RC
    Transplant Proc; 1998 Jun; 30(4):1009-11. PubMed ID: 9636408
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of kidney-bean leucoagglutinin on homograft rejection in mice.
    Weber TH; Mattsson A; Skoog VT; Räsänen V
    Experientia; 1973 Sep; 29(9):1140-1. PubMed ID: 4355419
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of interferon alpha/beta on cardiac allografts.
    Harihara Y; Sugawara Y; Inoue K; Kubota K; Bandai Y; Makuuchi M
    Transplant Proc; 1996 Jun; 28(3):1250-1. PubMed ID: 8658645
    [No Abstract]   [Full Text] [Related]  

  • 14. Prolongation of rat heart allografts by donor pretreatment with immunosuppressive agents.
    Freeman JS; Chamberlain EC; Reemtsma K; Steinmuller D
    Transplant Proc; 1971 Mar; 3(1):580-2. PubMed ID: 4937943
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunosuppressive therapy applied to allogenic lung transplants].
    Otte H; Grosjean O; Mulder M; Blumenstock D; Lejeune G; Honoré D; Leroux G
    Eur Surg Res; 1970; 2(3):213-20. PubMed ID: 4950496
    [No Abstract]   [Full Text] [Related]  

  • 16. Heart allograft rejection in rats triggered by H2 inhibitors.
    Olausson M; Wramner L; Blohmé I; Mjörnstedt L
    Transplant Proc; 1997 Nov; 29(7):3127-8. PubMed ID: 9365695
    [No Abstract]   [Full Text] [Related]  

  • 17. Spectrum of susceptibility to rejection of heart and multivisceral small bowel allografts using leflunomide immunosuppression.
    D'Silva M; DeRoover A; Nishimura Y; Antoniou E; Candinas D; Hubscher SG; McMaster P
    Transplant Proc; 1996 Apr; 28(2):948-9. PubMed ID: 8623475
    [No Abstract]   [Full Text] [Related]  

  • 18. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
    Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LF 08-0299 induces tolerance after short-term treatment in a fully major histocompatibility mismatched rat cardiac allograft model.
    Dutartre P; Annat J; Derrepas P
    Transplant Proc; 1995 Feb; 27(1):440-2. PubMed ID: 7879054
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunosuppression in cardiac transplantation.
    Rose EA; Addonizio LJ
    Bibl Cardiol; 1988; (43):1-9. PubMed ID: 3067706
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.